Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christine Perret

Showing results (1-10 of 99) with videos related to

Pageof 10
Sort By:
Medecine Sciences : M/S|December 13, 2021
Christine Perret
Annales D'Endocrinologie|April 10, 2013
General mechanisms of cancer cell metabolic adaptationChristine Perret
Journal of Hepatology|December 15, 2010
Methylation profile as a new tool for classification of hepatocellular carcinomaChristine Perret
Hepatology (Baltimore, Md.)|April 9, 2019
Letter to the Editor: Comment on Qiao et alHelene Gilgenkrantz, Christine Perret
Medecine Sciences : M/S|April 7, 2012
[Sirtuin 1, hepatic steatosis and liver cancer]Hélène Gilgenkrantz, Christine Perret
Future Oncology (London, England)|April 21, 2012
PKM2: a new player in the β-catenin gameFrédéric Canal, Christine Perret
Hepatology (Baltimore, Md.)|May 17, 2019
Mammalian Target of Rapamycin Inhibitors, New Drugs for Beta-Catenin-Mutated Hepatocellular Carcinomas?Christine Perret, Thomas Decaens
JAMA|June 16, 2005
Cost-effectiveness of ximelagatran for stroke preventionChristine Perret-Guillaume, Denis Wahl
Medecine Sciences : M/S|October 14, 2021
[LKB1, a gatekeeper of amino-acid driven gluconeogenesis]Pierre-Alexandre Just, Christine Perret
Progress in Molecular Biology and Translational Science|November 16, 2010
Molecular determinants of liver zonationCyril Torre, Christine Perret, Sabine Colnot
Pageof 10

Showing results (1-10 of 99) with videos related to

Sort By:
Pageof 10
Medecine Sciences : M/S|December 13, 2021
Christine Perret
Annales D'Endocrinologie|April 10, 2013
General mechanisms of cancer cell metabolic adaptationChristine Perret
Journal of Hepatology|December 15, 2010
Methylation profile as a new tool for classification of hepatocellular carcinomaChristine Perret
Hepatology (Baltimore, Md.)|April 9, 2019
Letter to the Editor: Comment on Qiao et alHelene Gilgenkrantz, Christine Perret
Medecine Sciences : M/S|April 7, 2012
[Sirtuin 1, hepatic steatosis and liver cancer]Hélène Gilgenkrantz, Christine Perret
Future Oncology (London, England)|April 21, 2012
PKM2: a new player in the β-catenin gameFrédéric Canal, Christine Perret
Hepatology (Baltimore, Md.)|May 17, 2019
Mammalian Target of Rapamycin Inhibitors, New Drugs for Beta-Catenin-Mutated Hepatocellular Carcinomas?Christine Perret, Thomas Decaens
JAMA|June 16, 2005
Cost-effectiveness of ximelagatran for stroke preventionChristine Perret-Guillaume, Denis Wahl
Medecine Sciences : M/S|October 14, 2021
[LKB1, a gatekeeper of amino-acid driven gluconeogenesis]Pierre-Alexandre Just, Christine Perret
Progress in Molecular Biology and Translational Science|November 16, 2010
Molecular determinants of liver zonationCyril Torre, Christine Perret, Sabine Colnot
Pageof 10